{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:07:45Z","timestamp":1791295665188,"version":"4.1.0"},"reference-count":54,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,9,3]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous hematologic malignancies. Ezh1 is essential to maintain hematopoiesis in the setting of Ezh2 loss.<\/jats:p>","DOI":"10.1182\/blood-2015-03-634428","type":"journal-article","created":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T22:21:15Z","timestamp":1438122075000},"page":"1172-1183","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":143,"title":["Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner"],"prefix":"10.1182","volume":"126","author":[{"given":"Makiko","family":"Mochizuki-Kashio","sequence":"first","affiliation":[{"name":"Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goro","family":"Sashida","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan;"},{"name":"International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiko","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Tomioka","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan;"},{"name":"Department of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Muto","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan;"},{"name":"College of Life Sciences, Inner Mongolia University, Hohhot, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Iwama","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111711420401200_B1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.stem.2014.05.006","article-title":"Chromatin repressive complexes in stem cells, development, and cancer.","volume":"14","author":"Laugesen","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"7","key":"2019111711420401200_B2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nsmb.2848","article-title":"Revolution in the Polycomb hierarchy.","volume":"21","author":"Comet","year":"2014","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"2019111711420401200_B3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.stem.2010.08.002","article-title":"Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer.","volume":"7","author":"Sauvageau","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2019111711420401200_B4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12185-014-1647-2","article-title":"Epigenetics of hematopoietic stem cell aging and disease.","volume":"100","author":"Oshima","year":"2014","journal-title":"Int J Hematol"},{"issue":"5","key":"2019111711420401200_B5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.stem.2012.08.001","article-title":"Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest.","volume":"11","author":"Hidalgo","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2019111711420401200_B6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.stem.2013.10.001","article-title":"Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner.","volume":"14","author":"Xie","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"25","key":"2019111711420401200_B7","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1182\/blood-2011-03-340554","article-title":"Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells.","volume":"118","author":"Mochizuki-Kashio","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2019111711420401200_B8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood-2011-11-394932","article-title":"Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia.","volume":"120","author":"Tanaka","year":"2012","journal-title":"Blood"},{"issue":"13","key":"2019111711420401200_B9","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1073\/pnas.1202258109","article-title":"Polycomb repressive complex 2 is required for MLL-AF9 leukemia.","volume":"109","author":"Neff","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019111711420401200_B10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood-2014-06-581082","article-title":"Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia.","volume":"125","author":"Xu","year":"2015","journal-title":"Blood"},{"key":"2019111711420401200_B11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncomms1623","article-title":"Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease.","volume":"3","author":"Herrera-Merchan","year":"2012","journal-title":"Nat Commun"},{"issue":"2","key":"2019111711420401200_B12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"issue":"8","key":"2019111711420401200_B13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ng.620","article-title":"Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.","volume":"42","author":"Nikoloski","year":"2010","journal-title":"Nat Genet"},{"issue":"8","key":"2019111711420401200_B14","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"issue":"26","key":"2019111711420401200_B15","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes.","volume":"364","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"2019111711420401200_B16","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes.","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2019111711420401200_B17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"issue":"6","key":"2019111711420401200_B18","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/leu.2013.80","article-title":"Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies.","volume":"27","author":"Khan","year":"2013","journal-title":"Leukemia"},{"issue":"1","key":"2019111711420401200_B19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/leu.2013.288","article-title":"EZH2 in normal and malignant hematopoiesis.","volume":"28","author":"Lund","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"2019111711420401200_B20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc3343","article-title":"The role of mutations in epigenetic regulators in myeloid malignancies.","volume":"12","author":"Shih","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"2019111711420401200_B21","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/onc.2014.196","article-title":"-7\/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity.","volume":"34","author":"Honda","year":"2015","journal-title":"Oncogene"},{"issue":"2","key":"2019111711420401200_B22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","article-title":"ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.","volume":"22","author":"Abdel-Wahab","year":"2012","journal-title":"Cancer Cell"},{"issue":"7","key":"2019111711420401200_B23","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/leu.2011.58","article-title":"Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms.","volume":"25","author":"Abdel-Wahab","year":"2011","journal-title":"Leukemia"},{"issue":"12","key":"2019111711420401200_B24","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1084\/jem.20131144","article-title":"Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders.","volume":"210","author":"Muto","year":"2013","journal-title":"J Exp Med"},{"key":"2019111711420401200_B25","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1038\/ncomms5177","article-title":"Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation.","volume":"5","author":"Sashida","year":"2014","journal-title":"Nat Commun"},{"issue":"12","key":"2019111711420401200_B26","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","article-title":"Clonal architecture of secondary acute myeloid leukemia.","volume":"366","author":"Walter","year":"2012","journal-title":"N Engl J Med"},{"issue":"22","key":"2019111711420401200_B27","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111711420401200_B28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.molcel.2008.10.016","article-title":"EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency.","volume":"32","author":"Shen","year":"2008","journal-title":"Mol Cell"},{"issue":"5","key":"2019111711420401200_B29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.neuron.2009.08.021","article-title":"Polycomb limits the neurogenic competence of neural precursor cells to promote astrogenic fate transition.","volume":"63","author":"Hirabayashi","year":"2009","journal-title":"Neuron"},{"issue":"5","key":"2019111711420401200_B30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1101\/gad.2019811","article-title":"EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair.","volume":"25","author":"Ezhkova","year":"2011","journal-title":"Genes Dev"},{"issue":"5","key":"2019111711420401200_B31","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1096\/fj.14-261537","article-title":"The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration.","volume":"29","author":"Bae","year":"2015","journal-title":"FASEB J"},{"issue":"43","key":"2019111711420401200_B32","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019111711420401200_B33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.stem.2014.03.002","article-title":"Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal.","volume":"14","author":"Sun","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2019111711420401200_B34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.2651","article-title":"Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia.","volume":"18","author":"Ntziachristos","year":"2012","journal-title":"Nat Med"},{"issue":"6937","key":"2019111711420401200_B35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature01587","article-title":"Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.","volume":"423","author":"Park","year":"2003","journal-title":"Nature"},{"issue":"10","key":"2019111711420401200_B36","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1084\/jem.20052477","article-title":"Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice.","volume":"203","author":"Oguro","year":"2006","journal-title":"J Exp Med"},{"issue":"8","key":"2019111711420401200_B37","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1371\/journal.pbio.0050201","article-title":"Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation.","volume":"5","author":"Chambers","year":"2007","journal-title":"PLoS Biol"},{"issue":"4","key":"2019111711420401200_B38","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/leu.2010.31","article-title":"Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.","volume":"24","author":"Pellagatti","year":"2010","journal-title":"Leukemia"},{"key":"2019111711420401200_B39","article-title":"Targeting EZH2 and PRC2 dependence as novel anticancer therapy [published online ahead of print May 28, 2015].","volume-title":"Exp Hematol","author":"Xu"},{"issue":"26","key":"2019111711420401200_B40","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes.","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111711420401200_B41","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111711420401200_B42","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies.","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"12","key":"2019111711420401200_B43","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1084\/jem.20131141","article-title":"Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo.","volume":"210","author":"Abdel-Wahab","year":"2013","journal-title":"J Exp Med"},{"issue":"7","key":"2019111711420401200_B44","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1101\/gad.186411.111","article-title":"A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia.","volume":"26","author":"Simon","year":"2012","journal-title":"Genes Dev"},{"key":"2019111711420401200_B45","article-title":"Novel biological insights in T-cell acute lymphoblastic leukemia [published online ahead of print June 26, 2015].","volume-title":"Exp Hematol","author":"Durinck"},{"issue":"7380","key":"2019111711420401200_B46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"issue":"4","key":"2019111711420401200_B47","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"issue":"1","key":"2019111711420401200_B48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2901","article-title":"The double life of a B-1 cell: self-reactivity selects for protective effector functions.","volume":"11","author":"Baumgarth","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2019111711420401200_B49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ni876","article-title":"Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement.","volume":"4","author":"Su","year":"2003","journal-title":"Nat Immunol"},{"issue":"5","key":"2019111711420401200_B50","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/leu.2013.364","article-title":"Tumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesis.","volume":"28","author":"Peters","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"2019111711420401200_B51","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.molcel.2014.12.009","article-title":"Developmental control of polycomb subunit composition by GATA factors mediates a switch to non-canonical functions.","volume":"57","author":"Xu","year":"2015","journal-title":"Mol Cell"},{"issue":"19","key":"2019111711420401200_B52","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1182\/blood-2013-02-451757","article-title":"The myelodysplastic syndrome as a prototypical epigenetic disease.","volume":"121","author":"Issa","year":"2013","journal-title":"Blood"},{"key":"2019111711420401200_B53","article-title":"Epigenetic aberrations in acute myeloid leukemia: early key events during leukemogenesis [published online ahead of print June 25, 2015].","volume-title":"Exp Hematol","author":"Eriksson"},{"issue":"7521","key":"2019111711420401200_B54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature13561","article-title":"PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies.","volume":"514","author":"De Raedt","year":"2014","journal-title":"Nature"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/10\/1172\/1389076\/1172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/10\/1172\/1389076\/1172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T11:42:29Z","timestamp":1573990949000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/126\/10\/1172\/73134\/Ezh2-loss-in-hematopoietic-stem-cells-predisposes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,3]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,9,3]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-03-634428","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,3]]}}}